NeueHealth FY 2023: revenue $1.2B, down 52%; diluted EPS −$150.94

Key figures from this report

These are the numbers NeueHealth reported for the year ended Dec 31, 2023, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$1.2B−52% from $2.4B in FY 202210-K income statement, on EDGAR
2. Net income−$1.2BAgainst −$1.5B in FY 202210-K income statement, on EDGAR
3. Diluted EPS−$150.94Against −$190.40 in FY 202210-K income statement, on EDGAR
4. Cash and cash equivalents$87.3M−81% from $466.3M in FY 2022Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
5. Cash from operations−$2.7B−1263% from $234.5M in FY 202210-K cash flow statement, on EDGAR